Company Filing History:
Years Active: 2024
Title: Ambara Rachmat Pradipta: Innovator in Pharmaceutical Chemistry
Introduction
Ambara Rachmat Pradipta is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of drugs that target specific chemical compounds.
Latest Patents
Pradipta holds a patent for a drug that reacts with acrolein, which is a compound known for its potential harmful effects. His patent, titled "Drug that reacts with acrolein, use thereof and novel compound," outlines a drug that contains a compound with a specific chemical structure. This innovative drug aims to mitigate the adverse effects associated with acrolein exposure.
Career Highlights
Ambara Rachmat Pradipta is associated with Riken Corporation, a leading research institution in Japan. His work at Riken has allowed him to focus on groundbreaking research in drug development and chemical reactions.
Collaborations
Pradipta collaborates with Katsunori Tanaka, a fellow researcher, to enhance the scope and impact of their work in pharmaceutical innovations.
Conclusion
Ambara Rachmat Pradipta's contributions to drug development highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.